Gender and sex play a part in detemining which topical products are most successful for patients. This table is compiled based on a review of articles form the International Journal of Women's Dermatology.

Skin differences in men and women

Patients that schedule regular mammograms could easily be encouraged to screen for melanoma via self-skin examination when given instructions at their breast cancer screenings, according to a recent study. This type of intervention program could be an effective strategy to increase skin cancer awareness.

Education at mammogram impacts skin cancer awareness

Patients in outpatient primary care clinics are choosing to learn about genomic testing to detemine their risk of melanoma, according to a recent clinical trial. 

Patients want genetic testing

Congress has proposed two bills that are designed to promote a "scientific exchange" between drug manufacturers and physcians. As a result, drug manufacturers may be able to share clinical data and non-FDA-approved uses of drugs with healthcare providers in the future.

The state of off-label drug laws

Combination treatment of dupilumab and topical corticosteroid treatment improved itch, mood and quality of life in adult patients with moderate-to-severe atopic dermatitis, according to a new trial.

Combined atopic dermatitis treatment shows promise

Cosmetic injections have increased in men, but men don’t often achieve the same results as women. To provide the same degree of success, dermatologists should take into consideration the more masculine features, according to several studies published recently.

Optimizing fillers for men

Dermatologists can use online patient reviews as a tool to educate patients about minimally-invasive fat reduction procedures, according to a new study.

The value of online patient reviews

AIVITA Biomedical, a biotech firm that focuses on regenerative medicines such as stem cell applications, recently named two new members to its senior management team.

AIVITA Biomedical names new CFO, VP of business development

Two dermatology practices join forces to deliver excellent treatment options to patients in El Paso, Texas.

Epiphany Dermatology partners with Sun City Dermatology

As more dermatologists implement EHR systems, many are wondering if EHR adoption will increase or decrease their medical legal liability. Dr. David Goldberg provides his insight in this month's legal column.

The burden of electronic health record implementation

In this month's Cosmetic Conundrums column, Dr. Draelos addresses cosmeceutical peptides and the differences between carrier peptides, signal peptides and neurotransmitter peptides.

What are cosmeceutical peptides?

In this month's Innovation Column, Drs. Steve Xu and William Ju discuss the unique advantage dermatologists have when it comes to innovation in healthcare.

A critical first step in defining great problems

When hurricanes Irma and Maria hit Puerto Rico in September 2017, the connections Dr. José Raúl Montes, an oculoplastic surgeon and frequent speaker at dermatology meetings, said that the connections he made through the years with peers and patients helped him stay afloat. Speaker and oculoplastic surgeon, José Raúl Montes, M.D., discusses how his love for music and passion for connection have lead him to train others on the proper use of injectables.

José Raúl Montes, M.D., sings a metaphor for injectable synergy

The FDA has approved Ortho Dermatologic’s new drug application for Altreno (tretinoin 0.05 percent) lotion for the treatment of acne vulgaris.

FDA approves tretinoin lotion acne treatment

Two dermatology firms combine to improve their medical and cosmetic dermatology services, existing treatments and procedures.

NYC, Philadelphia dermatology firms merge

Kleresca's new biophotonic technology received CE mark of approval, which will allow it to expand in the U.S., Canada, Australia and throughout Europe.

Biophotonic system earns CE mark

Developing doctor-patient relationships are key to avoiding oversimplification of characteristics like race and gender, which can result in stereotyping and medical mismanagement.

A framework for better medical management

A literature review by an international group of physicians shows that the physiological skin parameters differ among men and women suggesting that treatment choices should differ as well.

Male-female skin differences drive treatment choices

Can clinicians working for Catholic health care organizations prescribe the birth control pill for acne? A recent article discusses the ethical and legal problems these clinicians face when patients request to be treated with oral contraceptives.

Ethical dilemmas for physicians in Catholic healthcare organizations

People who use indoor tanners may be putting themselves at greater risk for skin cancer because they use low SPF sunscreen.

Indoor tanners lax on sunscreen protection

It might not be the first place dermatologists look, but diseases of the vulva are skin conditions. An itchy, sore vulva can be caused by a number of different skin conditions, said Dr. Gayle Fischer in a presentation given at the AAD Summer Meeting.

Vulvar diseases are skin diseases

Caring for gay men and other men who have sex with men in a dermatology settings requires medical knowledge and cultural sensitivity, but few dermatologists have had formal training in caring for this group of patients.

Caring for men who have sex with men

In inflammatory arthritis, the molecular and genetic makeup of synovial tissues appears to hold clues that one day may guide clinical decision-making. Re: EULAR report.

Synovial biopsies may hold psoriatic clues

Gestational diabetes, gestational hypertension and pre-eclampsia are higher in women with psoriasis or psoriatic arthritis.

Adverse pregnancy and birth outcomes higher in psoriasis

Pediatric melanomas are often misdiagnosed by physicians. Adolescents have a more aggressive disease course than children and are treated with adult protocols leading to chronic morbidity.

Melanoma subtypes differ in children and teens

For some patients with moderate to severe atopic dermatitis, the combination of dupilumab and corticosteroids may be necessary to control flares, a new study shows. Dupilumab is a proven treatment for AD, so where do we go from here? A physician writing in BJD suggests predictive modeling.

Dermatology Times, October 2018 (Vol. 39, No. 10)